AI Chips Made in America: Could This Change Everything?
Nvidia and TSMC have produced the first advanced AI chip wafer on U.S. soil, a landmark event for domestic manufacturing. This move to re-shore critical technology production creates a significant investment opportunity in the expanding American semiconductor supply chain.
Your Basket's Financial Footprint
Market capitalisation breakdown for the 'America's AI Chip Renaissance' basket. Summary key points and investor takeaways.
- Large-cap concentration generally means lower volatility and closer tracking to broader market performance.
- Suited as a core, long-term holding rather than a speculative, short-term trade.
- Likely to deliver steady long-term appreciation rather than explosive short-term gains.
NVDA: $4.45T
TSM: $1.23T
ASML: $397.24B
- Other
About This Group of Stocks
Our Expert Thinking
The production of the first advanced AI chip wafer on US soil represents a historic shift towards domestic semiconductor manufacturing. This strategic move to re-shore critical technology production creates compelling investment opportunities across the entire American semiconductor ecosystem, from chip designers to equipment manufacturers.
What You Need to Know
This group focuses on companies integral to building America's domestic chip manufacturing capacity. It's a tactical and cyclical investment targeting a structural shift in a high-growth technology sector, supported by significant public and private investment in national security and technological independence.
Why These Stocks
These companies were handpicked by professional analysts as key players across the semiconductor value chain. From industry leaders like Nvidia and TSMC to specialised suppliers of manufacturing equipment and materials, each firm is positioned to benefit from the long-term expansion of American semiconductor production.
Why You'll Want to Watch These Stocks
Historic Manufacturing Milestone
The first advanced AI chip wafer produced on US soil marks a pivotal moment in American technology independence. This landmark achievement signals the beginning of a new era in domestic semiconductor manufacturing.
Massive Investment Wave Coming
Billions in public and private investment are flowing into US semiconductor infrastructure. Companies positioned in this supply chain could see sustained growth as domestic production scales up significantly.
National Security Priority
Re-shoring critical chip production is now a strategic imperative for America. This government-backed initiative creates long-term tailwinds for companies building out domestic manufacturing capabilities.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Railroad Investment: Beyond the $85 Billion Merger
Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.
Oracle TikTok Deal May Boost Stocks in 2025
TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.